Cancer Patients Europe

Working to improve the lives of the cancer community

The European Health Technology Assessment Regulation: the political will
Webinar

Tuesday, 28 February 2023, 15:00-16:30 CET

In order to support the development or strengthening the cooperation among all relevant stakeholders and better understand the role that patients can play in the process, Pancreatic Cancer Europe and Cancer Patients Europe are organising a webinar to exchange views on how best to enhance the cooperation on the HTA process.

myC: first European-wide patient survey in genomic testing in breast cancer

On the 17th of November 2022, CPE launched the results of the first European-wide patient survey in genomic testing in breast cancer. 4 out of 5 breast cancer patients eligible for genomic testing are not told it is available to them. The survey was completed by a total of 1,383 respondents from five countries (France, Germany, Italy, Spain, UK) over a six-week period in September/October 2022. Eighty-three percent (83%) of respondents had breast cancer; 50% of whom were eligible for genomic testing.

1. Lack of a Pan European Organisation across the European region with a balanced representation of cancer patients from all European countries

2. Growing need to bridge the European and the national dimensions

3. Only a transparent and credible organization can leverage the current prioritization of cancer care and treatment in Europe for the benefit of cancer patients

Vision and Mission

CPE’s Vision

Reduce the burden of cancer on patients and survivors, their carers, the health care systems and the society as a whole

CPE’s Mission

Represent and empower the voices of cancer patients and cancer survivors towards policymakers and other stakeholders, with the ultimate objective of co-creating policies that drive prevention, high-quality cancer care, treatment and survivorship in Europe.